Amedisys Inc (AMED) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 57 from a previous price target of $49 . Mizuho advised their investors in a research report released on Apr 11, 2016.
Many Wall Street Analysts have commented on Amedisys Inc. Oppenheimer Upgraded Amedisys Inc on Feb 8, 2016 to ” Outperform”, Price Target of the shares are set at $40.Company shares were Upgraded by Mizuho on Jan 19, 2016 to ” Buy”, Firm has raised the Price Target to $ 49 from a previous price target of $45 .
On the company’s financial health, Amedisys Inc reported $0.40 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Mar 8, 2016. Analyst had a consensus of $0.35. The company had revenue of $338.37 million for the quarter, compared to analysts expectations of $322.02 million. The company’s revenue was up 12.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.27 EPS.
Amedisys Inc closed down -0.03 points or -0.06% at $47.84 with 2,66,734 shares getting traded on Monday. Post opening the session at $48.22, the shares hit an intraday low of $47.67 and an intraday high of $48.76 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
In a different news, on Sep 25, 2015, Scott G Ginn (Principal Accounting Officer) sold 3,063 shares at $46.33 per share price. According to the SEC, on Aug 19, 2015, Donald A Washburn (director) sold 20,000 shares at $45.51 per share price. On Jul 31, 2015, Bruce D Perkins (director) purchased 3,000 shares at $43.07 per share price, according to the Form-4 filing with the securities and exchange commission.
Amedisys Inc. (Amedisys) is a health care at home company. Amedisys delivers home health and hospice care to more than 360000 patients each year. The Company has care network across 34 states. As of December 31 2014 it owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers. The Company operates through two segments: home health and hospice. The Companys home health segment delivers a range of services in the homes of individuals who may be recovering from surgery have a chronic disability or terminal illness or need assistance with the essential activities of daily living. The Companys hospice segment provides palliative care and comfort to terminally ill patients and their families.